AARDEX Group

Want to prevent patient #adherence issues in your #clinical #trials? Our CEO and Scientific Lead, Bernard Vrijens, PhD, will be in Boston from November 10-15, ready to discuss how we can help mitigate non-adherence risks in your studies. Connect with Bernard at the CNS Summit to explore strategies that secure patient adherence and engagement and improve trial outcomes. Don’t miss the opportunity - reach out to set up a time!

When it comes to clinical trials, are we truly measuring what we think we are? The TOPCAT trial's surprising adherence findings reveal that self-reported data may not always tell the full story, with non-compliance often hiding in plain sight. In an industry that relies on precision, flawed adherence tracking can introduce serious variability—and even compromise study outcomes. In our latest blog, we explore how accurate adherence data is critical to valid conclusions and why digital measurement methods are transforming trial reliability. Read more about creating rock-solid evidence for your trial’s success in our blog below. #AardexGroup #ClinicalTrials #Adherence #DataIntegrity

Consistent dosing isn't just ideal - it is essential for accurate results and patient safety. An inconsistent dosing regime can lead to reduced efficacy, occasional toxicity, and even drug resistance. But there is a better way!   Discover how Aardex captures, monitors, and analyses dosing data with absolute precision, creating confidence for sponsors, trialists, and, most importantly, patients. Watch the video to learn more! 🎥    #ClinicalTrials #PharmaInnovation #PatientAdherence #MedicalResearch

AARDEX is heading to Naples for the 28th ESPACOMP Conference! Join us on November 21-22 as our CEO, Bernard Vrijens, leads discussions on Precision Dosing and the future of medication adherence. Curious about what’s on the agenda? Read our latest blog for an inside look at this year’s themes and AARDEX’s key research presentations ⬇️ #AardexGroup #ESPACOMP #ESPACOMP2024 #MedicationAdherence #PrecisionDosing

🔥 Looking to stay on top of the latest trends in medicine? Join Bernard Vrijens, PhD, AARDEX Group's CEO and Scientific Lead, as he shares his insights into the challenges and innovations in patient #adherence and patient #safety. Discover with us the Hot Topics for Acute Physicians, a monthly webinar series organized by the Royal College of Physicians of Ireland. This month’s focus: Pharmaceutical Medicine and ensuring patient safety during the drug discovery process. Don’t miss out, secure your spot now: 👉 https://eur.cvent.me/NR9wg

Meet Jean-Michel Biollaz, Product & Process Manager    I am honoured to be a part of the original team at the inception of AARDEX Group in 2000. It has been a personal and professional point of pride to see how the organisation and its offer has evolved over that time, from being an optional service provider for clinical trials to a fundamental cog in the process to establish optimal dosing for new drugs.     During the past 25 years I have held numerous roles ranging from software development to IT and QA, continuously building my skills and expertise to meet the growing needs of all stakeholders, both internal and external. I am currently part of the Product Management team, acting as the Product and Process Manager, where I leverage my cross-functional expertise to enhance our products and processes.    Right from the outset we have developed our proprietary software in-house, ensuring complete control over this critical part of our value proposition. As a result, we have built an enterprise-wide expertise in managing adherence data across our diverse range of products, including web and mobile applications.     This product portfolio, complemented by our unique expertise and experience in medication adherence and patient compliance enables us to acquire, monitor, analyse, guide and interpret data to deliver absolute clarity and bring confidence to sponsors, trialists, and ultimately, patients.     You can follow Jean-Michel here - https://lnkd.in/e5UAxSCd #AARDEXGroup #MeetTheTeam #AdherenceMatters

In this exclusive interview, we sit down with Joe Keenan, AARDEX's Senior Director of Business Development, to explore his career path and his bold vision for the future of medication adherence in clinical trials.   From engineering to business development, Joe’s insights tackle the critical need for smarter solutions that aren’t just optional—they’re essential.   Read the full interview below.    #AdherenceMatters #AARDEXGroup #MeetTheTeam

The rise of GLP-1 receptor agonist therapies has been nothing short of revolutionary for Type 2 diabetes and obesity treatment. But as promising as these 'wonder drugs' are, effective oral delivery remains complex, often affecting patient adherence.   Our latest blog dives into the intricacies of GLP-1 dosing, from bioavailability hurdles to gastrointestinal side effects, and the need for precise, patient-centric dosing regimens. Read the full article below or click here - https://lnkd.in/etJE8fxU   To achieve a breakthrough in individualised dosing, robust data on drug exposure is key. At AARDEX, we provide the adherence solutions needed to gather and interpret these critical insights—bringing clarity and confidence to every step of your clinical trial journey.   #PharmaceuticalResearch #AARDEXGroup #researchanddevelopment #ClinicalTrials #MedicationAdherence

🚀 Exciting news from AARDEX Group! We’ve teamed up with OnDosis to push the boundaries of what’s possible in clinical trials and precision medicine. 🌟 This partnership is all about revolutionizing #drug #dosing and making patient care more precise, effective, and safe. Why does this matter? Because optimizing how patients take their medications is at the heart of better health outcomes and clinical trials results. 💊💥 We’re expanding our #MEMS® ecosystem to bring the innovations that ensure patients get the right dose, every time. Here's to transforming clinical trials together and setting new standards for the future of clinical trials. 🙌 https://lnkd.in/e36ZyvKW #AARDEX #OnDosis #Partnership #ClinicalInnovation #PrecisionDosing #MEMS

Calling all Acute Physicians! 🚨 Join AARDEX Group and Royal College of Physicians of Ireland at this CPD-accredited webinar, where our CEO and scientific lead, Bernard Vrijens, will focus on drug discovery, patient adherence, and patient safety. Register here: https://lnkd.in/e_F2Wp52 #patient #adherence #safety #AARDEX